In contrast, our study provides causal evidence supporting the protective effect of increased LPL expression on IBD and CD, and we identified potential mediators, such as genus Clostridium sens stricto 1, Ruminococcaceae UCG009, IL-18, and MIP-1a. Here, CCL3 is linked to inflammatory bowel disease.